About This Compound

This formulation is a blended synthetic research peptide supplied in lyophilized powder form. Scientific classification: Combined GHRH analog and growth hormone secretagogue research blend Scientific representation: CJC-1295 (a GHRH receptor analog) combined with Ipamorelin (a selective GHS-R agonist) Published pharmacology research has characterized the two peptides' receptor-binding profiles and their frequently studied combined effect on pulsatile growth hormone release in research models. Intended Use: For laboratory research purposes only. Not intended for human use, diagnostic, clinical, or therapeutic applications.